One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal Afib Dual-energy (RF/PF), focal Sphere-9™ catheter demonstrates efficacy for linear ablation in persistent…
Tag: AFib
XYRA Announces the Issuance of a Fifth New US Patent in a Series of Patents Which Protect the Use of Budiodarone in the Management of Atrial Fibrillation till after 2040
Budiodarone shown in Phase 2 to reduce atrial fibrillation symptoms and long episodes of atrial fibrillation (LEAF) FDA gives guidance on steps necessary to gain approval and incorporate wearable AF monitoring devices into label for budiodarone Five granted US patents align with FDA’s…
UNLIMITED HEART HEALTH and WELLNESS PARTNERS WITH NUDJ HEALTH TO REVOLUTIONIZE THE FUTURE OF AFIB CARE
BOSTON, March 12, 2025 /PRNewswire/ — Unlimited Heart Health & Wellness is proud to announce a groundbreaking partnership with Nudj Health, marking a major advancement in guidelines-based AFib care and holistic lifestyle management. AFib is a growing crisis, and while we have built a…
Data Published Today in the New England Journal of Medicine Demonstrates Anthos Therapeutics’ novel Factor XI inhibitor, Abelacimab 150mg, Reduced Major or Clinically Relevant Non-Major Bleeding by 62% Compared to Rivaroxaban (Xarelto) in Patients with Atrial Fibrillation
Secondary endpoints also showed a highly significant 67% reduction in major bleeding and an 89% reduction in gastrointestinal (GI) bleeding The company’s AZALEA-TIMI 71 study is the longest head-to-head study of a Factor XI inhibitor vs. a direct oral anticoagulant (DOAC) CAMBRIDGE, Mass., Jan. 22, 2025 (GLOBE NEWSWIRE) — Anthos Therapeutics, Inc., a transformative, clinical-stage…
FDA Grants De Novo Authorization to OMRON Healthcare for New Blood Pressure Monitors with AI-Powered AFib Detection Feature
Advancing its Going for Zero mission, OMRON innovation makes AFib screening an integral part of the brand’s routine home blood pressure monitoring experience HOFFMAN ESTATES, Ill., Nov. 14, 2024 /PRNewswire/ — In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare…
St. Joseph’s Hospital’s ‘Tampa 2’ AFib Procedure Contributes to Tampa Bay Legacy of Success
The Tampa 2 procedure was created to be easy to replicate while achieving equal or better outcomes compared to the Cox-Maze IV, a widely used surgical intervention for AFib introduced in 2002. AFib is a cardiac condition noted by an irregular, frequently rapid heart rhythm and is typically treated with prescription, catheter-based and/or surgical interventions.
“We created the Tampa 2 procedure after years of collaboration between cardiology and cardiac surgery in conjunction with surgical pioneer Dr. James Cox (originator of the Cox-Maze IV procedure). This state-of-the-art technique has the potential to redefine surgical management of atrial fibrillation,” said Dr. Sherman.
Like its predecessor, the Tampa 2 creates scar tissue to block abnormal electrical signals that cause AFib but adds two lines of ablation (the method to create scar tissue) and has a different approach made possible by new tools and technology. The Tampa 2 achieved its namesake because of the two additional lines of ablation, developed by two Tampa physicians, all while tipping their hat to the success the Tampa Bay Buccaneers had with their Tampa 2 defense. More than 50 successful Tampa 2 procedures have been performed at St. Joseph’s Hospital, including the treatment of Brittany Williams, a patient of Dr. Sherman. Now the benefits of the Tampa 2 procedure extend beyond the walls of St. Joseph’s Hospital as Dr. Sherman and Dr. Makati host lectures across the country to train physicians on all aspects of AFib treatment. In addition, the two physicians presented their procedure and clinical findings at the 2024 International Society for Minimally Invasive Cardiothoracic Surgery annual meeting in Athens, Greece (see abstract here).”We are very proud that this novel procedure was developed here at BayCare and St. Joseph’s Hospital,” said Dr. Makati. “We are excited to continually offer new, lifesaving procedures to our community and beyond. This is only possible by the innovative spirit and collaborative efforts of our colleagues here in Tampa and around the world.” For more information about the Heart Institute at St. Joseph’s Hospital: https://baycare.org/locations/hospitals/st-josephs-hospital/services/heart-and-vascular About St. Joseph’s HospitalSt. Joseph’s Hospital, part of the BayCare Health System, is known for advanced medical technology and compassionate care. Its Centers of Excellence include the Heart and Vascular Institute, Cancer Institute, Stroke and Neuroscience Program, Robotic Surgery Program and Emergency/Trauma Department, which provides more emergency care than any other hospital in Tampa Bay. More than 70 specialties are represented among the medical team, including internal medicine, cardiovascular surgery and neurosurgery. The hospital was founded in 1934 by the Franciscan Sisters of Allegany. The 615-bed hospital is located at 3001 West Dr. Martin Luther King Jr. Boulevard in Tampa, Florida. For more information: BayCare.org/SJH.About BayCareBayCare is a leading not-for-profit health care system that connects individuals and families to a wide range of services at 16 hospitals and hundreds of other convenient locations throughout the Tampa Bay and central Florida regions. The system is West Central Florida’s largest provider of behavioral health and pediatric services and its provider group, BayCare Medical Group, is one of the largest in the region. BayCare’s diverse network of ambulatory services includes laboratories, imaging, surgical centers, BayCare Urgent Care locations, wellness centers and one of Florida’s largest home care agencies, BayCare HomeCare. BayCare’s mission is to improve the health of all it serves through community-owned, health care services that set the standard for high-quality, compassionate care. For more information visit BayCare.org.SOURCE BayCare Health System
Cardiovascular Centers of America Announces Cardiac Ablation Service Line at Advanced Heart and Vascular in Deltona, Florida
DELTONA, Fla., April 17, 2024 /PRNewswire/ — Cardiovascular Centers of America (CCA) proudly announces the launch of Florida’s the first complete cardiac ablation service line in an Ambulatory Surgery Center (ASC) at Advanced Heart and Vascular Surgery Center (Advanced Cardiovascular)….
GE HealthCare Launches CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care
CHICAGO–(BUSINESS WIRE)–Today, GE HealthCare (Nasdaq: GEHC) announces the launch of CardioVisio for Atrial Fibrillation (AFib), a digital tool designed to assist clinicians in visualizing longitudinal data relevant for disease progression from multiple data sources, and driving evidence based clinical decision support directed by up-to-date AFib guidelines. The new technology will […]
Volta Medical Announces Initiation of RESTART Clinical Trial for Treatment of Repeat Atrial Fibrillation
Interventional study to evaluate long term outcomes of Volta’s AI solution-supported ablation in recurrent-AF patients who failed previous ablation International, multi-center trial at 21 sites with results expected in 2025 MARSEILLE, France, June 22, 2023 (GLOBE NEWSWIRE) — Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions […]
Progressing Clinical Evidence: CathVision Announces First Patient Enrolled In Persistent AF Study at OLV Hospital Aalst
Series of Clinical Studies Highlight Advantages of ECGenius System and CARDIALYTICS Suite of Algorithms COPENHAGEN, Denmark, April 17, 2023 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions to enhance clinical decision-making in the EP lab, today announced initial patient enrollment of a follow-on clinical study to demonstrate the value […]